Wikipedia -WSS

Wikipedia

author：focus 2025-09-30 00:46:11 - browse：4342

A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT — A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

Next stop: Beacon Hill.

Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： Bristol Myers buys into radiopharmaceuticals with RayzeBio

focus

WSS

What STAT readers think about the FDA and patient advocacy

Virtual care provider acquires bankrupt Pear's prescription apps

As a primary care physician, here's how I hope to partner with AI

Reports of telehealth's death have been greatly exaggerated

Keeping primary care docs in field isn't impossible, says AAFP CEO

Citing H5N1 threat, CDC urges peak flu monitoring this summer

entertainment

Wikipedia

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Humana’s Medicare Advantage lawsuit should be tossed, DOJ says

At least 13 dead in Texas as scorching temps continue

Three trends to watch in biotech in 2024

Apple is now the first public company to be valued at $3 trillion

SEC charges former device maker CEO with $41 million fraud

Affirmative action in medical school literally saved lives

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Medical records are filled with copy

Biogen joins immunology wave with $1.15 billion acquisition of HI

leisure time

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

HCA sued by state AG for quality issues at Mission Health

Prime Medicine, Myeloid Therapeutics clash over genome

Drinking less cuts risk of oral cavity, esophageal cancer: Report

Grail spinoff by Illumina should end disastrous merger attempt

ASCO eve: Let’s set the table for this year's meeting

focus

focus

entertainment

focus